Diabetes Clinical Trials in Arizona

57 recruiting studies across 3 cities

Browse by City

Mesa

All Trials in Arizona

Phase

Trial	Phase	Sponsor	Dist.
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus	Phase 3	AstraZeneca	<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	Phase 3	Boehringer Ingelheim	<1 mi
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment	N/A	Aventyn, Inc.	<1 mi
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes	Phase 2	Eli Lilly and Company	<1 mi
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight	Phase 3	Novo Nordisk A/S	<1 mi
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar	Phase 3	Boehringer Ingelheim	<1 mi
Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus	N/A	Well Cell Global	<1 mi
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin	Phase 3	Eli Lilly and Company	<1 mi
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema	Phase 2/3	AbbVie	<1 mi
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)	Phase 3	Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics	<1 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma	Phase 2	Children's Oncology Group	<1 mi
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes	Phase 3	Kailera	<1 mi
Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for African American Women	Phase 2	Arizona State University	<1 mi
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth	—	George Washington University	<1 mi
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide	Phase 2	Eli Lilly and Company	<1 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes	Phase 4	VA Office of Research and Development	<1 mi
Early Tracking of Childhood Health Determinants (ETCHED) Study	—	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	<1 mi
EDX110 Randomized Control Trial for Treatment of DFUs	N/A	ConvaTec Inc.	<1 mi
Efficacy of Placental Membrane Dressings in Accelerating Diabetic Foot Healing	Phase 4	BioXTek	<1 mi
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)	—	University of New Mexico	<1 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)	Phase 2/3	CSL Behring	<1 mi
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes	Phase 3	Kailera	<1 mi
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial	N/A	Sonavex, Inc.	<1 mi
Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue	Phase 1	Ayu, Inc.	<1 mi
Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers	N/A	Reprise Biomedical, Inc.	<1 mi
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes	Phase 3	Ascletis Pharma (China) Co., Limited	<1 mi
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers	N/A	Piomic Medical	<1 mi
Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems	N/A	RxFunction Inc.	<1 mi
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus	Phase 2	Hanmi Pharmaceutical Company Limited	<1 mi
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus	Phase 3	AstraZeneca	<1 mi
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)	Phase 2	Sparrow Pharmaceuticals	3 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events	N/A	Cleerly, Inc.	3 mi
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial	Phase 2	Jason Sperry	3 mi
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight	Phase 2	Eli Lilly and Company	3 mi
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)	Phase 1/2	COUR Pharmaceutical Development Company, Inc.	3 mi
DFC 004 Biomarkers for Active Diabetic Foot Ulcers	—	University of Michigan	3 mi
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)	Phase 3	Eli Lilly and Company	3 mi
Diabetic Foot Ulcer (DFU) Biofilm Infection and Recurrence	—	University of Pittsburgh	3 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes	Phase 3	Eli Lilly and Company	3 mi
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes	Phase 3	Hoffmann-La Roche	3 mi
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes	Phase 3	Hoffmann-La Roche	3 mi
Kidney Precision Medicine Project	—	Icahn School of Medicine at Mount Sinai	3 mi
Arizona CEAL: Linking Social Care With Healthcare Systems to Address SDOH	N/A	Sairam Parthasarathy	3 mi
WatchWell: Simple and Practical Strategies to Reduce the Negative Health Impact of Sedentary Screen Time	N/A	Arizona State University	5 mi
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)	Phase 3	Amgen	5 mi
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)	Phase 1/2	GI Innovation, Inc.	8 mi
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes	Phase 4	Brigham and Women's Hospital	8 mi
Gastroparesis Registry 4	—	Johns Hopkins Bloomberg School of Public Health	8 mi
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes	Phase 3	Sanofi	8 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes	Phase 3	Eli Lilly and Company	8 mi
A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study)	N/A	Aqua Medical, Inc.	8 mi
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM	Phase 3	AstraZeneca	8 mi
A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity	Phase 2	Antag Therapeutics	8 mi
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications	Phase 3	Novo Nordisk A/S	8 mi
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies	—	AstraZeneca	13 mi
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes	Phase 3	Kailera	15 mi
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin	Phase 3	AstraZeneca	15 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.